ATE276357T1 - Reinigung von vitamin-k abhaengigen proteinen durch membrane chromatographie - Google Patents

Reinigung von vitamin-k abhaengigen proteinen durch membrane chromatographie

Info

Publication number
ATE276357T1
ATE276357T1 AT95903324T AT95903324T ATE276357T1 AT E276357 T1 ATE276357 T1 AT E276357T1 AT 95903324 T AT95903324 T AT 95903324T AT 95903324 T AT95903324 T AT 95903324T AT E276357 T1 ATE276357 T1 AT E276357T1
Authority
AT
Austria
Prior art keywords
vitamin
purification
dependent proteins
membrane chromatography
protein
Prior art date
Application number
AT95903324T
Other languages
English (en)
Inventor
Djuro Josic
Ales Strancar
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of ATE276357T1 publication Critical patent/ATE276357T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/647—Blood coagulation factors not provided for in a preceding group or according to more than one of the proceeding groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
AT95903324T 1993-12-10 1994-12-07 Reinigung von vitamin-k abhaengigen proteinen durch membrane chromatographie ATE276357T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4342132A DE4342132C1 (de) 1993-12-10 1993-12-10 Verfahren zur Herstellung virusinaktivierte Vitamin K abhängige Plasmakomponenten sowie Protein C und Protein S enthaltender Mittel durch Membran-Chromatographie
PCT/EP1994/004067 WO1995016030A1 (en) 1993-12-10 1994-12-07 Purification of vitamin-k dependent proteins by membrane chromatography

Publications (1)

Publication Number Publication Date
ATE276357T1 true ATE276357T1 (de) 2004-10-15

Family

ID=6504650

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95903324T ATE276357T1 (de) 1993-12-10 1994-12-07 Reinigung von vitamin-k abhaengigen proteinen durch membrane chromatographie

Country Status (19)

Country Link
US (2) US20020045240A1 (de)
EP (1) EP0733104B1 (de)
JP (1) JPH09506256A (de)
KR (1) KR100320394B1 (de)
CN (1) CN1175105C (de)
AT (1) ATE276357T1 (de)
AU (1) AU682560B2 (de)
CA (1) CA2178208C (de)
CZ (1) CZ291708B6 (de)
DE (2) DE4342132C1 (de)
DK (1) DK0733104T3 (de)
ES (1) ES2224119T3 (de)
HU (1) HU222084B1 (de)
IL (1) IL111925A (de)
PL (1) PL180179B1 (de)
PT (1) PT733104E (de)
UA (1) UA44261C2 (de)
WO (1) WO1995016030A1 (de)
ZA (1) ZA949820B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT409334B (de) * 1997-09-19 2002-07-25 Immuno Ag Pharmazeutisches präparat enthaltend vitamin k-abhängige einzelfaktoren
US7932365B2 (en) 2003-11-08 2011-04-26 Pro Thera Biologics, Llc Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
JP2005315666A (ja) * 2004-04-28 2005-11-10 Toshihiko Hanai 糖結合充填剤およびその製造方法
EP1831242B1 (de) * 2004-12-23 2012-09-26 Novo Nordisk Health Care AG Reduktion des gehaltes an kontaminierenden proteinen in zusammensetzungen, die vitamin k-abhängige proteine von interesse umfassen
KR100667860B1 (ko) 2005-10-18 2007-01-11 주식회사 녹십자 고순도 사람 혈액응고 제9인자의 정제 방법
CN103025757A (zh) * 2010-04-29 2013-04-03 巴克斯特国际有限公司 二价阳离子结合蛋白在阴离子交换树脂上的纯化方法
EP2652491B1 (de) 2010-12-15 2017-11-29 Baxalta GmbH Eluatsammlung mit leitfähigkeitsgradient
CN103665098B (zh) * 2012-09-20 2015-08-05 中国科学院大连化学物理研究所 双相柱膜蛋白质微反应器及其应用
CN104447975A (zh) * 2014-11-18 2015-03-25 深圳市人口和计划生育科学研究所 一种提取人肿瘤细胞膜蛋白的方法
WO2019086463A1 (en) 2017-10-30 2019-05-09 Baxalta GmbH Environmentally compatible detergents for inactivation of lipid-enveloped viruses
CN111378029B (zh) * 2018-12-29 2023-05-05 四川远大蜀阳药业有限责任公司 一种人凝血因子ix的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3173208D1 (en) * 1980-10-06 1986-01-23 Edward Shanbrom Method of reducing undesirable activities of biological and pharmaceutical products
DE3045153A1 (de) * 1980-11-29 1982-07-08 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung von blutgerinnungsfaktoren und danach hergestellte praeparation der faktoren ix und x
US4820805A (en) * 1983-07-14 1989-04-11 New York Blood Center, Inc. Undenatured virus-free trialkyl phosphate treated biologically active protein derivatives
US4540573A (en) * 1983-07-14 1985-09-10 New York Blood Center, Inc. Undenatured virus-free biologically active protein derivatives
EP0229026B1 (de) * 1986-01-06 1995-11-22 Blood Systems Inc, an Arizona not-for-profit corporation Therapeutisches Blutprodukt, Mittel und Verfahren zu dessen Erzeugung
ES2045167T5 (es) * 1987-10-23 1996-07-01 Centre Regional De Transfusion Preparacion de concentrado de factor ix humano de elevada pureza y de otras proteinas plasmaticas.
CA2001720C (en) * 1988-10-31 2001-10-02 Randal A. Goffe Membrane affinity apparatus and purification methods related thereto
DE3914869C1 (de) * 1989-05-05 1990-08-09 Biotest Pharma Gmbh, 6072 Dreieich, De
CA2073511A1 (en) * 1990-11-14 1992-05-29 Matthew R. Callstrom Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins
AT402261B (de) * 1991-01-25 1997-03-25 Immuno Ag Komplex enthaltend den gerinnungsfaktor ix
AT402891B (de) * 1991-06-20 1997-09-25 Immuno Ag Verfahren zur herstellung eines inaktivierten blutproduktes
DE4204694C3 (de) * 1992-02-01 1995-10-12 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem Faktor VIII mittels Anionenaustauscher-Chromatographie

Also Published As

Publication number Publication date
IL111925A0 (en) 1995-03-15
HU9601594D0 (en) 1996-07-29
DE4342132C1 (de) 1994-11-03
AU1242595A (en) 1995-06-27
CA2178208C (en) 2009-06-02
CN1175105C (zh) 2004-11-10
PL314801A1 (en) 1996-09-30
CZ291708B6 (cs) 2003-05-14
PT733104E (pt) 2004-12-31
CZ167096A3 (en) 1996-09-11
KR100320394B1 (ko) 2002-07-31
EP0733104B1 (de) 2004-09-15
ES2224119T3 (es) 2005-03-01
CA2178208A1 (en) 1995-06-15
ZA949820B (en) 1995-08-16
CN1137292A (zh) 1996-12-04
HUT76881A (en) 1997-12-29
UA44261C2 (uk) 2002-02-15
PL180179B1 (pl) 2000-12-29
AU682560B2 (en) 1997-10-09
US20020045240A1 (en) 2002-04-18
EP0733104A1 (de) 1996-09-25
DK0733104T3 (da) 2005-01-17
IL111925A (en) 2000-06-01
US20020182582A1 (en) 2002-12-05
DE69434001T2 (de) 2005-09-22
JPH09506256A (ja) 1997-06-24
DE69434001D1 (de) 2004-10-21
WO1995016030A1 (en) 1995-06-15
HU222084B1 (hu) 2003-04-28
US6893856B2 (en) 2005-05-17

Similar Documents

Publication Publication Date Title
Owen et al. Activation of prothrombin with Oxyuranus scutellatus scutellatus (Taipan snake) venom
Downing et al. Human prothrombin activation
Boissel et al. Covalent structures of beta and gamma autolytic derivatives of human alpha-thrombin.
McMullen et al. The occurrence of β-hydroxyaspartic acid in the vitamin K-dependent blood coagulation zymogens
Kitamoto et al. Hen egg white ovomacroglobulin has a protease inhibitory activity
DE69434001D1 (de) Reinigung von vitamin-k abhaengigen proteinen durch membrane chromatographie
DK426386D0 (da) Fremgangsmaade til rensning og aktivering af proteiner fra uoploeselige inklusionslegemer
DK98581A (da) Middel med fibronectin-lignende aktivitet og fremgangsmaade til dets fremstilling
DK0496725T3 (da) Kompleks indeholdende koagulationsfaktor IX
DK485589D0 (da) Fremgangsmaade til oprensning af proteiner
JPS6485096A (en) Hybrid human protein c and biotechnological synthesis thereof
Seegers et al. Some activation characteristics of the prethrombin subunit of prothrombin
AU569896B2 (en) Process for the dissolution of peptides and proteins
Voellmy et al. ATP-stimulated endoprotease is associated with the cell membrane of E. coli
Kisiel et al. Isolation of a protein C activator from southern copperhead venom
Legrand et al. Separation of human blood platelet elastase and proelastase by affinity chromatography
Wicher et al. Interactions of Bacillus subtilis alkaline proteinases with α2-macroglobulin and α1-antitrypsin
HUT69604A (en) Process for splitting of proteins
Owen et al. Evidence for an ester bond between thrombin and heparin cofactor
ES8900018A1 (es) Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos inhibidores de la renina y de las proteasas acidas
Bendjennat et al. Purification and characterization of a Ca2+-independent endoprotease activity from peripheral blood lymphocytes: involvement in HIV-1 gp160 maturation
Callaway et al. Use of lectin affinity chromatography for the purification of collagenase from human polymorphonuclear leukocytes
Söder et al. Characterization of trypsin-like enzymes from human saliva isolated by use of affinity chromatography
Sullivan et al. Detection and analysis of neutral endopeptidase from tissues with substrate gel electrophoresis
Cohen et al. Partial purification and characterization of the high molecular weight latent collagenase from human leukocytes

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0733104

Country of ref document: EP